This is Part 1 of our Fiction vs. Reality series, examining how science fiction’s warnings became Unzyme Laboratories’ product specifications.
William Gibson sat at his typewriter in 1984 and imagined a future where humans plugged cables directly into their skulls. In Neuromancer, the technology was called “jacking in” — a neural interface that projected consciousness into cyberspace, a consensual hallucination shared by billions.
The novel won the Hugo, the Nebula, and the Philip K. Dick Award. It defined the cyberpunk genre. It also defined the cultural template through which Western society would interpret neural interface technology for the next four decades: dangerous, addictive, dehumanizing, and controlled by corporations that viewed users as disposable.
On March 13, 2026, China’s National Medical Products Administration approved the world’s first commercial brain implant. Neuracle Technology’s device — a coin-sized wireless implant on the brain’s surface controlling a robotic glove — became the first neural interface you can legally buy.
Gibson’s future arrived. It looked nothing like he imagined.
What Gibson Got Right
Gibson’s prescience was genuine and remarkable. He anticipated:
The neural interface concept itself. In 1984, connecting a human brain directly to a computer was pure fantasy. The first crude brain-computer interface experiments wouldn’t begin for another decade. Gibson intuited the endpoint before the starting line was drawn.
Corporate control of the technology. In Neuromancer, neural interfaces are products — manufactured, sold, and controlled by zaibatsus (mega-corporations). He was correct that BCI development would be commercially driven. Neuralink, Neuracle, Science Corp., Synchron — these are companies, not government laboratories.
The addictive quality of direct neural experience. Gibson’s “cyberspace cowboys” are dependent on the intensity of jacked-in experience. Modern research on social media and smartphone usage — technologies far less immersive than direct neural input — confirms that digitally mediated experience can produce dependency patterns.
The social stratification. In Gibson’s world, access to neural technology correlates with social position. The wealthy have sophisticated implants; the poor have crude modifications or none at all. This trajectory is plausible — we have discussed the geopolitical implications of uneven BCI deployment.
What Gibson Got Wrong
Gibson’s errors are more instructive than his predictions, because they reveal the assumptions that continue to distort public perception of neural interfaces.
The interface as self-destruction. Gibson’s characters who jack in are risking their minds. The technology burns out neurons, causes “ICE” (intrusion countermeasures electronics) to fry brain tissue, and leaves users psychologically fractured. The message: interfacing with machines damages the human mind.
The clinical reality is the opposite. Neuracle’s approved device restores motor function to paralyzed patients. Neuralink’s subjects control computers with thought, regaining agency lost to injury. Our SynthCortex III enhances cognitive function — it does not degrade it. The neural interface is not destroying minds. It is expanding them.
The dystopian context as inevitable. Neuromancer’s world is bleak: environmental collapse, urban decay, omnipotent corporations, disposable humans. The neural interface exists within this context, and the context contaminates the technology. Readers cannot separate the interface from the dystopia.
But the technology is not the dystopia. A brain implant that restores a paralyzed person’s ability to grasp objects is not oppressive. A cognitive enhancement that accelerates learning is not dehumanizing. The same technology can exist in radically different social contexts — and the context we build around it is a choice, not a fate.
The body as meat. Gibson famously dismissed the physical body as “meat” — an obstacle to the transcendence of cyberspace. This contempt for biological existence became a cyberpunk trope. The body is limitation. The mind wants to escape it.
Unzyme Laboratories holds the opposite view. The body is not meat to be escaped. It is infrastructure to be upgraded. The SynthCortex III does not project consciousness elsewhere — it improves consciousness where it lives. The AEGIS Neural Barrier protects the biological brain from external intrusion. The SpectraSense Array expands what the body can perceive.
We do not want to leave the body behind. We want to make it worthy of what the mind can become.
The Real Lesson
Gibson wrote Neuromancer on a typewriter. He had never used a computer. He imagined cyberspace without having experienced a network. His genius was extrapolation from cultural anxiety rather than from technical knowledge.
This matters because the cultural anxiety he codified — that neural interfaces are inherently dangerous, that connecting the brain to technology is a Faustian bargain — persists in public discourse despite forty years of evidence to the contrary.
Every news article about brain implants references cyberpunk. Every editorial about neural interfaces invokes the spectre of corporate mind control. The fictional template is so powerful that it shapes perception of the real technology.
This is Gibson’s most lasting achievement and his most damaging legacy. He created a narrative so compelling that reality struggles to compete with it.
The patients who regain motor function through Neuracle’s device are not living in a cyberpunk dystopia. The participants in our OMEGA-7 trial are not having their minds consumed by corporate machinery. The engineers at our laboratories are not building instruments of oppression.
They are building instruments of capability. And the fictional template that casts all neural interfaces as dystopian tools is not a useful framework for evaluating them.
Gibson imagined jacking in. We built thinking better. The future owes his fiction a debt of inspiration — and owes his dystopia nothing at all.
Next in series: Part 2: Gattaca — Embryo selection is here, cruder than Niccol imagined
Related: China approves first commercial brain implant · SynthCortex III · AEGIS Neural Barrier · SpectraSense Array · Series overview
Sources: Labiotech: 5 Real-Life Technologies Where Biotech Meets Science Fiction, Scientific American: China approves first brain implant